This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients (ITX5061)

This study has been completed.
Sponsor:
Collaborators:
University Hospital Birmingham
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
University of Birmingham
ClinicalTrials.gov Identifier:
NCT01292824
First received: February 9, 2011
Last updated: December 1, 2015
Last verified: December 2015